SCHEDULE: Point72 Discloses 5.2% Stake in STAAR Surgical

Point72 Asset Management, L.P., along with affiliated entities and Steven A. Cohen, has reported beneficial ownership of 5.2% of STAAR Surgical Company's common stock as of May 11, 2026.

Summary

• Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G, indicating their beneficial ownership of STAAR Surgical Company's common stock.
• The filing, dated May 11, 2026, reports a total of 2,591,498 shares, representing 5.2% of the class of securities.
• Point72 Asset Management manages the shares through investment funds, with Point72 Capital Advisors Inc. acting as the general partner and Steven A. Cohen controlling both entities.
• The reporting persons disclaim beneficial ownership beyond their pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports an existing ownership stake and does not contain new operational or financial performance information.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Management Comments

• The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock reported herein.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by Point72 Asset Management indicates a significant institutional investor has taken a notable position in STAAR Surgical Company, a key player in the ophthalmic device market, particularly known for its EVO Visian ICL product line.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant institutional ownership, which can influence market perception and trading dynamics.

Key Dates

Keywords

STAAR Surgical Company, Point72 Asset Management, Schedule 13G, Beneficial Ownership, Investment Fund, Securities Filing